English
Polski
Español
українська
Challenges of long-term HIV treatment
What are the key obstacles and challenges in long-term treatment of HIV-positive patients?
2018-11-08
What are the key obstacles and challenges in long-term treatment of HIV-positive patients?
When should prophylactic antibiotics be considered during travel? What type of antibiotic and what treatment duration are recommended?
What should be the main strategies to control the epidemics of HIV/AIDS?
When could we expect no new cases of AIDS being reported in the European Union?
Are there any pending pharmacokinetic studies of antiretroviral drugs in the elderly?
Do antacids affect the risk of traveler’s diarrhea?
How often is neuropathic pain caused by antiviral drugs in HIV treatment?
Is there a risk of H7N9 influenza spreading from China to other countries?
Should members of the hospital personnel who do not have direct contact with patients and who are carriers of a multidrug-resistant strain, such as methicillin-resistant Staphylococcus aureus, continue to work as normal?
Is a confirmed carrier status of methicillin-resistant Staphylococcus aureus (MRSA) or other drug-resistant bacteria in a health-care worker an indication for treatment? Should the worker refrain from having contact with patients?
